(VIANEWS) – Shares of Viking Therapeutics (NASDAQ Composite: VKTX) fell 5.09% to $4.39 at 14:32 EST on Wednesday, after two successive sessions in a row of losses. NASDAQ Composite is dropping 1.53% to $15,383.54, following the last session’s downward trend. This seems, as yet, an all-around negative trend trading session today.
Viking Therapeutics’s last close was $4.62, 54.21% below its 52-week high of $10.09.
Today’s last reported volume for Viking Therapeutics is 727455 which is 4.32% above its average volume of 697277.
The company’s growth estimates for the current quarter and the next is a negative 61.5% and a negative 46.7%, respectively.
Viking Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.55%, a negative 0.12%, and a positive 2.62%, respectively.
Viking Therapeutics’s highest amplitude of average volatility was 3.86% (last week), 3.01% (last month), and 2.62% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Viking Therapeutics’s stock is considered to be oversold (<=20).
Viking Therapeutics’s Stock Yearly Top and Bottom Value
Viking Therapeutics’s stock is valued at $4.39 at 14:32 EST, below its 52-week low of $4.81.
Viking Therapeutics’s Moving Average
Viking Therapeutics’s value is way under its 50-day moving average of $5.82 and way under its 200-day moving average of $6.03.
More news about Viking Therapeutics (VKTX).